A double-blind, placebo-controlled, 4-arm, Phase 2B study to asses the efficacy and safety of a 14-Day dosing regimen of 3 doses of ATB-346 versus Placebo, orally administered once daily to male and female patients diagnosed with Osteoarthritis of the Knee.

Register Today!

Let others know about this Trial!

Trial Information

Start DateDecember 2019
End DateJan/Feb 2020
Trial Duration2 Months
Number of Visits6
Lead CRCJessica Richer

For additional information on this trial contact: